Showing Results for
- Academic Journals (129)
Search Results
- 129
Academic Journals
- 129
-
From:PLoS ONE (Vol. 8, Issue 4) Peer-ReviewedBats are reservoir animals harboring many important pathogenic viruses and with the capability of transmitting these to humans and other animals. To establish an effective surveillance to monitor transboundary spread of...
-
From:Bulletin of the World Health Organization (Vol. 99, Issue 11) Peer-ReviewedOn 16 September 2021, the Ministry of Health of Guinea declared the end of the Marburg virus disease outbreak in Gueckedou prefecture, Nzerekore Region. The declaration was made 42 days after the burial of the only...
-
From:PLoS ONE (Vol. 8, Issue 4) Peer-ReviewedAuthor(s): Laura J. Sherwood, Andrew Hayhurst * Introduction Viruses are usually experts in energetic economy, employing multiple copies of a relatively small repertoire of key architectural templates to assemble...
-
From:Nature (Vol. 514, Issue 7524) Peer-ReviewedTo much of the world, the virus behind the devastating Ebola outbreak in Africa seems to have stormed out of nowhere. But Leslie Lobel thinks we should have seen it coming. In 2012, Lobel and a team of researchers...
-
From:Emerging Infectious Diseases (Vol. 16, Issue 2) Peer-ReviewedTo the Editor: Lake Victoria Marburgvirus (MARV) causes severe hemorrhagic fever with a high case-fatality rate in humans. Index cases occurred in Europe during 1967 among laboratory workers who handled tissues and...
-
From:Emerging Infectious Diseases (Vol. 25, Issue 8) Peer-ReviewedWe detected Marburg virus genome in Egyptian fruit bats (Rousettus aegyptiacus) captured in Zambia in September 2018. The virus was closely related phylogenetically to the viruses that previously caused Marburg outbreaks...
-
From:PLoS ONE (Vol. 7, Issue 1) Peer-ReviewedAuthor(s): Daniel R. Beniac 1 , Pasquale L. Melito 1 , Shauna L. deVarennes 1 , Shannon L. Hiebert 1 , Melissa J. Rabb 1 , 2 , Lindsey L. Lamboo 1 , 3 , Steven M. Jones 1 , Timothy F. Booth 1 , 2 , * Introduction...
-
From:Emerging Infectious Diseases (Vol. 26, Issue 9) Peer-ReviewedAfter the 2017 Ebola virus (EBOV) outbreak in Likati, a district in northern Democratic Republic of the Congo, we sampled small mammals from the location where the primary case-patient presumably acquired the infection....
-
From:PLoS ONE (Vol. 6, Issue 1) Peer-ReviewedThe Ebola fusion peptide (EBO.sub.16) is a hydrophobic domain that belongs to the GP2 membrane fusion protein of the Ebola virus. It adopts a helical structure in the presence of mimetic membranes that is stabilized by...
-
From:Emerging Infectious Diseases (Vol. 25, Issue 5) Peer-ReviewedWe conducted a serologic survey of 2,430 serum samples collected during 1997-2012 for various studies to determine the prevalence of the hemorrhagic fever virus Ebola virus (EBOV) in equatorial Africa. We screened serum...
-
From:Immunotherapy (Vol. 5, Issue 5) Peer-ReviewedAuthor(s): Ayato Takada 1 KEYWORDS : antibody therapy; Ebola virus; envelope glycoprotein; filovirus; Marburg virus; nonhuman primates; passive immunization; virus neutralization Filoviruses, including Ebola...
-
From:Nature Medicine (Vol. 16, Issue 9) Peer-ReviewedCurrently, no vaccines or therapeutics are licensed to counter Ebola or Marburg viruses, highly pathogenic filoviruses that are causative agents of viral hemorrhagic fever. Here we show that administration of positively...
-
From:Primate Biology (Vol. 2, Issue 1) Peer-ReviewedIt took almost 20 years from the first proposal for the foundation of a German primate centre to the final establishment of an institute for research on primates. Since 1964, the German science community had considered...
-
From:Future Virology (Vol. 2, Issue 6)Author(s): Peter L Collins 1 , Alexander Bukreyev [[dagger]] 2 Marburg (MARV) and Ebola (EBOV) viruses are enveloped viruses (family Filoviridae ) with a single negative-sense strand of genomic RNA of more than 19...
-
From:Future Virology (Vol. 1, Issue 2)Author(s): Ulrich Desselberger After a long interval, this meeting took up an almost forgotten tradition of joint Scandinavia-UK meetings, and gathered approximately 150 participants, two-thirds of them from Norway,...
-
From:PLoS ONE (Vol. 12, Issue 6) Peer-ReviewedUnder a traditional paradigm, only those with the expected background knowledge consume academic literature. The lay press, as well as government and non-government agencies, play a complementary role of extracting...
-
From:Expert Review of Vaccines (Vol. 7, Issue 4) Peer-ReviewedAuthor(s): Dana L Swenson 1 , Kelly L Warfield 2 , Tom Larsen 3 , D Anthony Alves 4 , Sadie S Coberley 5 , Sina Bavari [[dagger]] 6 Keywords: antibody; Ebola; filovirus; Marburg; nonhuman primate; protective...
-
From:Future Virology (Vol. 2, Issue 6)Author(s): Keita Matsuno 1 , Ayato Takada [[dagger]] 2 Keywords: antibody therapy; Ebola virus; monoclonal antibody; passive immunization Ebola virus (EBOV) is a nonsegmented, negative-strand RNA virus, and...
-
From:PLoS ONE (Vol. 4, Issue 5) Peer-ReviewedBackground Zaire ebolavirus (ZEBOV) produces a lethal viral hemorrhagic fever in humans and non-human primates. Methodology/Principal Findings We demonstrate that the VSV[DELTA]G/ZEBOVGP vaccine given 28 days...
-
From:CMAJ: Canadian Medical Association Journal (Vol. 186, Issue 16) Peer-ReviewedIn early August, amid rising alarm about Ebola, immunologist Eleanor Fish of the University Health Network in Toronto contacted a friend in Sierra Leone to say that the antiviral drug interferon might be helpful. There...